i3S-Hovione Capital Innovation Award

The i3S-Hovione Capital Innovation Prize is an international award aiming to promote new medical devices, diagnostic systems and health monitoring technologies. With a global value of more than € 35,000.00, the idea is to identify new science-based products and technologies science and new start- ups in the health sector. The event itself is an instrument to create multiple synergies between investors and entrepreneurs, providing notoriety and opportunities for partnership and investment, both for the winners and for all competitors.

 

In addition to selecting a great winner to be honored by Hovione Capital, other entities will also be represented, and will also present a prize to one of the finalists, among which we highlight Aescuvest (from EIT-Saúde) and ANI (National Agency of Innovation), which will also award the BfK (Born From Knowledge) prize in the same session. The selection and awarding session will take place on February 4 at i3S between 2:30 p.m. and 5:30 p.m. and will include presentations of the 8 finalist projects before the jury, partners and other entities of the innovation ecosystem.

The finalist teams are:

  • MechALife (powered by INEGI / FEUP), an active exoskeleton for lower limbs to assist daily activities;
  • NeuroQ (powered by INESC-TEC), a wearable device for assessing the stiffness of the wrist as a support for neurosurgical procedures of Deep Brain Stimulation;
  • CBmeter (powered by Polytechnic Leiria / CEDOC), a medical device for diagnosing carotid function associated with metabolic diseases;
  • C'mo (powered by EBIMed), a wearable device for continuous patient cough monitoring;
  • Retinal imaging (powered by Imperial College London) with a device that makes the retinal image for diagnosis of systemic diseases accessible, easier and faster;
  • MalariaScope (powered by Fraunhofer Portugal / INSA), a solution for pre-diagnosis of malaria based on mobile devices supported by Artificial Intelligence;
  • HECOLCAP (powered by i3S), a device for phased antibiotic delivery to combat bone infection;
  • NBiON (powered by University of Minho), multifunctional magnetoliposomes for delivery of drugs for treatment of cancer.

Each team will make a 5-minute pitch to present their project, followed by 10 minutes of questions.

 

The jury comprises Peter Villax (President) and Ricardo Perdigão (Hovione Capital); Hugo Prazeres and João Cortez (i3S - Research and Innovation Unit); Jorg Diehl (Ascuvest); Alípio da Torre and André Faustino.